Discovering The Potential of TEX28 as A Drug Target and Biomarker

Target Name: TEX28

NCBI ID: G1527

Discovering The Potential of TEX28 as A Drug Target and Biomarker

TEX28 (MrX99) is a drug target and a biomarker that is being studied for its potential in treating various diseases, including cancer. It is a protein that is expressed in various tissues and cells in the body, including the brain, and has been shown to play a role in several cellular processes.

One of the main things that makes TEX28 an interesting drug target is its role in the regulation of cell division. The team that studied it found that TEX28 helps to control the number of cells that divide in the brain, which is important for the development and progression of many diseases, including cancer.

Another potential mechanism by which TEX28 may work as a drug target is its role in the regulation of blood vessel formation. The team that studied it found that TEX28 helps to control the growth and development of blood vessels, which is important for many diseases, including heart disease and diabetes.

In addition to its potential as a drug target, TEX28 has also been shown to be a potential biomarker. The team that studied it found that TEX28 levels are elevated in the brains of people with certain types of cancer, which could be used as a diagnostic marker for these diseases.

Overall, the team that studied TEX28 found that it is a promising drug target and biomarker for the treatment of various diseases. Further research is needed to fully understand its potential and to develop safe and effective treatments.

Protein Name: Testis Expressed 28

More Common Targets

AREAS

Q&A

STOCKS

TARGETS

CONTACT

BD@bio.cacnex.com